ID   PDE7A_HUMAN             Reviewed;         482 AA.
AC   Q13946; A0AVH6; A8K436; A8K9G5; O15380; Q96T72;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   22-JUL-2015, entry version 148.
DE   RecName: Full=High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A;
DE            EC=3.1.4.53;
DE   AltName: Full=HCP1;
DE   AltName: Full=TM22;
GN   Name=PDE7A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE7A1).
RX   PubMed=8389765;
RA   Michaeli T., Bloom T.J., Martins T., Loughney K., Ferguson K.,
RA   Riggs M., Rodgers L., Beavo J.A., Wigler M.;
RT   "Isolation and characterization of a previously undetected human cAMP
RT   phosphodiesterase by complementation of cAMP phosphodiesterase-
RT   deficient Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 268:12925-12932(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE7A2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=9195912; DOI=10.1074/jbc.272.26.16152;
RA   Han P., Zhu X., Michaeli T.;
RT   "Alternative splicing of the high affinity cAMP-specific
RT   phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart.";
RL   J. Biol. Chem. 272:16152-16157(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE7A3).
RX   PubMed=11371644; DOI=10.1073/pnas.101131098;
RA   Glavas N.A., Ostenson C., Schaefer J.B., Vasta V., Beavo J.A.;
RT   "T cell activation up-regulates cyclic nucleotide phosphodiesterases
RT   8A1 and 7A3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:6319-6324(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PDE7A1).
RC   TISSUE=Kidney, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PDE7A2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH CBFA2T3.
RX   PubMed=15470020; DOI=10.4049/jimmunol.173.8.4806;
RA   Asirvatham A.L., Galligan S.G., Schillace R.V., Davey M.P., Vasta V.,
RA   Beavo J.A., Carr D.W.;
RT   "A-kinase anchoring proteins interact with phosphodiesterases in T
RT   lymphocyte cell lines.";
RL   J. Immunol. 173:4806-4814(2004).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 130-482 IN COMPLEX WITH
RP   METAL IONS AND THE INHIBITOR IBMX.
RX   PubMed=15994308; DOI=10.1074/jbc.M504398200;
RA   Wang H., Liu Y., Chen Y., Robinson H., Ke H.;
RT   "Multiple elements jointly determine inhibitor selectivity of cyclic
RT   nucleotide phosphodiesterases 4 and 7.";
RL   J. Biol. Chem. 280:30949-30955(2005).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 139-456 IN COMPLEX WITH
RP   METAL IONS, FUNCTION, AND COFACTOR.
RX   PubMed=19350606; DOI=10.1002/cmdc.200900043;
RA   Castano T., Wang H., Campillo N.E., Ballester S., Gonzalez-Garcia C.,
RA   Hernandez J., Perez C., Cuenca J., Perez-Castillo A., Martinez A.,
RA   Huertas O., Gelpi J.L., Luque F.J., Ke H., Gil C.;
RT   "Synthesis, structural analysis, and biological evaluation of
RT   thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors.";
RL   ChemMedChem 4:866-876(2009).
CC   -!- FUNCTION: Hydrolyzes the second messenger cAMP, which is a key
CC       regulator of many important physiological processes. May have a
CC       role in muscle signal transduction. {ECO:0000269|PubMed:19350606}.
CC   -!- CATALYTIC ACTIVITY: Adenosine 3',5'-cyclic phosphate + H(2)O =
CC       adenosine 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000269|PubMed:19350606};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000269|PubMed:19350606};
CC   -!- ENZYME REGULATION: Insensitive to all selective PDE inhibitors.
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from
CC       3',5'-cyclic AMP: step 1/1.
CC   -!- SUBUNIT: Interacts with CBFA2T3. {ECO:0000269|PubMed:15470020,
CC       ECO:0000269|PubMed:15994308, ECO:0000269|PubMed:19350606}.
CC   -!- SUBCELLULAR LOCATION: Isoform PDE7A1: Cytoplasm, cytosol.
CC       Note=PDE7A1 (57 kDa) is located mostly to soluble cellular
CC       fractions.
CC   -!- SUBCELLULAR LOCATION: Isoform PDE7A2: Cytoplasm. Note=PDE7A2 (50
CC       kDa) is located to particulate cellular fractions.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=PDE7A1;
CC         IsoId=Q13946-1; Sequence=Displayed;
CC       Name=PDE7A2;
CC         IsoId=Q13946-2; Sequence=VSP_004593;
CC       Name=PDE7A3;
CC         IsoId=Q13946-3; Sequence=VSP_038645, VSP_038646;
CC   -!- TISSUE SPECIFICITY: PDE7A1 is found at high levels in skeletal
CC       muscle and at low levels in a variety of tissues including brain
CC       and heart. It is expressed as well in two T-cell lines. PDE7A2 is
CC       found abundantly in skeletal muscle and at low levels in heart.
CC   -!- DEVELOPMENTAL STAGE: Developmentally regulated. PDE7A1 and PDE7A2
CC       are found in several fetal tissues, expression is reduced
CC       throughout development. It persists strongly only in adult
CC       skeletal muscle.
CC   -!- DOMAIN: Composed of a C-terminal catalytic domain containing two
CC       putative divalent metal sites and an N-terminal regulatory domain.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. PDE7 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12052; AAA35644.2; -; mRNA.
DR   EMBL; U67932; AAB65772.1; -; mRNA.
DR   EMBL; AF332652; AAK57640.1; -; mRNA.
DR   EMBL; AK290801; BAF83490.1; -; mRNA.
DR   EMBL; AK292680; BAF85369.1; -; mRNA.
DR   EMBL; AC055822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC100812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC126360; AAI26361.1; -; mRNA.
DR   CCDS; CCDS34901.1; -. [Q13946-2]
DR   CCDS; CCDS56538.1; -. [Q13946-1]
DR   RefSeq; NP_001229247.1; NM_001242318.2. [Q13946-1]
DR   RefSeq; NP_002594.1; NM_002603.3. [Q13946-2]
DR   RefSeq; XP_011515842.1; XM_011517540.1. [Q13946-2]
DR   UniGene; Hs.527119; -.
DR   PDB; 1ZKL; X-ray; 1.67 A; A=130-482.
DR   PDB; 3G3N; X-ray; 2.40 A; A=139-456.
DR   PDB; 4PM0; X-ray; 2.10 A; A=130-482.
DR   PDB; 4Y2B; X-ray; 2.20 A; A=130-482.
DR   PDBsum; 1ZKL; -.
DR   PDBsum; 3G3N; -.
DR   PDBsum; 4PM0; -.
DR   PDBsum; 4Y2B; -.
DR   ProteinModelPortal; Q13946; -.
DR   SMR; Q13946; 139-456.
DR   BioGrid; 111176; 4.
DR   IntAct; Q13946; 1.
DR   STRING; 9606.ENSP00000385632; -.
DR   BindingDB; Q13946; -.
DR   ChEMBL; CHEMBL2363066; -.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB00651; Dyphylline.
DR   DrugBank; DB00920; Ketotifen.
DR   GuidetoPHARMACOLOGY; 1305; -.
DR   PhosphoSite; Q13946; -.
DR   BioMuta; PDE7A; -.
DR   DMDM; 3182958; -.
DR   MaxQB; Q13946; -.
DR   PaxDb; Q13946; -.
DR   PRIDE; Q13946; -.
DR   DNASU; 5150; -.
DR   Ensembl; ENST00000379419; ENSP00000368730; ENSG00000205268. [Q13946-2]
DR   Ensembl; ENST00000396642; ENSP00000379881; ENSG00000205268. [Q13946-3]
DR   Ensembl; ENST00000401827; ENSP00000385632; ENSG00000205268.
DR   GeneID; 5150; -.
DR   KEGG; hsa:5150; -.
DR   UCSC; uc003xvp.3; human. [Q13946-2]
DR   UCSC; uc003xvq.3; human. [Q13946-1]
DR   UCSC; uc003xvr.3; human. [Q13946-3]
DR   CTD; 5150; -.
DR   GeneCards; GC08M066629; -.
DR   HGNC; HGNC:8791; PDE7A.
DR   HPA; CAB018770; -.
DR   HPA; HPA027340; -.
DR   MIM; 171885; gene.
DR   neXtProt; NX_Q13946; -.
DR   PharmGKB; PA33139; -.
DR   eggNOG; NOG300643; -.
DR   GeneTree; ENSGT00760000118889; -.
DR   HOGENOM; HOG000220881; -.
DR   HOVERGEN; HBG053543; -.
DR   KO; K18436; -.
DR   OMA; LCDRQTE; -.
DR   OrthoDB; EOG7M98G3; -.
DR   PhylomeDB; Q13946; -.
DR   TreeFam; TF314638; -.
DR   BRENDA; 3.1.4.53; 2681.
DR   Reactome; REACT_19327; G alpha (s) signalling events.
DR   UniPathway; UPA00762; UER00747.
DR   ChiTaRS; PDE7A; human.
DR   EvolutionaryTrace; Q13946; -.
DR   GeneWiki; PDE7A; -.
DR   GenomeRNAi; 5150; -.
DR   NextBio; 19872; -.
DR   PRO; PR:Q13946; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; Q13946; -.
DR   CleanEx; HS_PDE7A; -.
DR   ExpressionAtlas; Q13946; baseline and differential.
DR   Genevisible; Q13946; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; TAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00471; HDc; 1.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; cAMP; Complete proteome;
KW   Cytoplasm; Hydrolase; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    482       High affinity cAMP-specific 3',5'-cyclic
FT                                phosphodiesterase 7A.
FT                                /FTId=PRO_0000198833.
FT   REGION      187    451       Catalytic. {ECO:0000250}.
FT   COMPBIAS     28     33       Poly-Ser.
FT   ACT_SITE    212    212       Proton donor. {ECO:0000250}.
FT   METAL       216    216       Divalent metal cation 1.
FT   METAL       252    252       Divalent metal cation 1.
FT   METAL       253    253       Divalent metal cation 1.
FT   METAL       253    253       Divalent metal cation 2.
FT   METAL       362    362       Divalent metal cation 1.
FT   MOD_RES      84     84       Phosphoserine. {ECO:0000255}.
FT   VAR_SEQ       1     46       MEVCYQLPVLPLDRPVPQHVLSRRGAISFSSSSALFGCPNP
FT                                RQLSQ -> MGITLIWCLALVLIKWITSK (in isoform
FT                                PDE7A2). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9195912}.
FT                                /FTId=VSP_004593.
FT   VAR_SEQ     416    424       FMTYLVEPL -> NYTYLDIAG (in isoform
FT                                PDE7A3). {ECO:0000303|PubMed:11371644}.
FT                                /FTId=VSP_038645.
FT   VAR_SEQ     425    482       Missing (in isoform PDE7A3).
FT                                {ECO:0000303|PubMed:11371644}.
FT                                /FTId=VSP_038646.
FT   VARIANT      76     76       G -> E (in dbSNP:rs11557049).
FT                                /FTId=VAR_056661.
FT   CONFLICT    204    204       D -> G (in Ref. 4; BAF83490).
FT                                {ECO:0000305}.
FT   HELIX       140    148       {ECO:0000244|PDB:1ZKL}.
FT   TURN        149    152       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       158    164       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       169    180       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       183    186       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       191    203       {ECO:0000244|PDB:1ZKL}.
FT   STRAND      209    213       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       214    228       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       231    234       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       239    251       {ECO:0000244|PDB:1ZKL}.
FT   TURN        252    255       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       261    266       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       270    274       {ECO:0000244|PDB:1ZKL}.
FT   TURN        275    277       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       280    296       {ECO:0000244|PDB:1ZKL}.
FT   TURN        297    301       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       304    319       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       323    325       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       326    339       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       347    362       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       365    367       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       370    393       {ECO:0000244|PDB:1ZKL}.
FT   TURN        404    406       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       409    419       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       421    431       {ECO:0000244|PDB:1ZKL}.
FT   HELIX       435    453       {ECO:0000244|PDB:1ZKL}.
SQ   SEQUENCE   482 AA;  55505 MW;  3B3C8F6E9154F88C CRC64;
     MEVCYQLPVL PLDRPVPQHV LSRRGAISFS SSSALFGCPN PRQLSQRRGA ISYDSSDQTA
     LYIRMLGDVR VRSRAGFESE RRGSHPYIDF RIFHSQSEIE VSVSARNIRR LLSFQRYLRS
     SRFFRGTAVS NSLNILDDDY NGQAKCMLEK VGNWNFDIFL FDRLTNGNSL VSLTFHLFSL
     HGLIEYFHLD MMKLRRFLVM IQEDYHSQNP YHNAVHAADV TQAMHCYLKE PKLANSVTPW
     DILLSLIAAA THDLDHPGVN QPFLIKTNHY LATLYKNTSV LENHHWRSAV GLLRESGLFS
     HLPLESRQQM ETQIGALILA TDISRQNEYL SLFRSHLDRG DLCLEDTRHR HLVLQMALKC
     ADICNPCRTW ELSKQWSEKV TEEFFHQGDI EKKYHLGVSP LCDRHTESIA NIQIGFMTYL
     VEPLFTEWAR FSNTRLSQTM LGHVGLNKAS WKGLQREQSS SEDTDAAFEL NSQLLPQENR
     LS
//
